You have requested access to member only content.

Q&A: What you need to know about compounding medicine

The Joint Commission unveiled a new Medication Compounding Certification (MCC) program in January with the goal of reducing the harm stemming from drug compounding and ensuring compliance with U.S. Pharmacopeial Convention (USP) and Joint Commission standards. Meanwhile, USP Chapter <800> goes into effect on December 1, 2019 and contains major changes aimed at protecting healthcare workers from exposure to hazardous drugs and materials.
Kurt Patton, MS, RPh, a former director of accreditation services for The Joint Commission and founder of Patton Healthcare Consulting in Naperville, Illinois spoke with BOAQ on the details surrounding medication compounding.

This is an excerpt from members-only content. Please log in or become a member to access the full content.

Not a member? Let's fix that!

A membership to Accreditation and Quality Compliance Center provides accreditation and safety professionals with a collection of continuously updated tools, best-practice strategies, and compliance tips developed by industry experts. With two membership options, you can customize your access level depending on your education and training needs.

Register to access the free content available on the site or become a member today. Click here for more information.

For questions and support, please call customer service: 800-650-6787.